The CRISPR-Based Diagnostics Market was valued at US$ 3,102.33 Million in 2024 and is projected to expand at a CAGR of 16.93% from 2025 to 2032. Market growth is supported by the rising global burden of infectious diseases, increasing prevalence of genetic disorders and cancer, growing demand for rapid and decentralized point-of-care (POC) diagnostics, and continuous advancements in CRISPR-Cas...